The effect of systemic administration of WIN55212‐2 on (a) analgesia, (b) hypothermia, (c) catalepsy and (d) immobility in WT, CB1‐KO, CB2‐KO, and GPR55‐KO mice. *P < .05, as compared to vehicle. #
P < .05, as compared to the baseline before the WIN55212‐2 treatment. For WT, n = 10; for CB1‐KO, n = 8; for CB2‐KO, n = 9; for GPR55‐KO, n = 8